Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,172
Closed -$40K 447
2018
Q3
$40K Buy
+11,172
New +$430K ﹤0.01% 372
2018
Q1
Sell
-10,435
Closed -$359K 257
2017
Q4
$359K Buy
+10,435
New +$356K ﹤0.01% 216
2017
Q1
Sell
-42,160
Closed -$1.3M 290
2016
Q4
$1.3M Hold
42,160
0.05% 126
2016
Q3
$1.35M Buy
+42,160
New +$1.41M 0.08% 113
2016
Q2
Sell
-5,979,764
Closed -$168M 277
2016
Q1
$168M Buy
5,979,764
+5,948,144
+18,811% +$170M 6.32% 5
2015
Q4
$968K Buy
+31,620
New +$995K 0.07% 152
2015
Q1
Sell
-210,800
Closed -$6K 428
2014
Q4
$6K Buy
+210,800
New +$6.04M ﹤0.01% 200
2014
Q3
Sell
-276,991
Closed -$7.8M 320
2014
Q2
$7.8M Buy
+276,991
New +$7.9M 0.88% 21
2013
Q3
Sell
-18,550
Closed -$493K 265
2013
Q2
$493K Buy
+18,550
New +$513K 0.05% 155

Other funds holding PFE

Cowen Inc's PFE Position: Q4 2018 in Review

Cowen Inc sold out of Pfizer (PFE) in Q4 2018, closing a stake of 22 shares — an estimated $1K sold.

Cowen Inc first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $4.24M in Q2 2013. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Cowen Inc reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Cowen Inc sold 22 Pfizer shares in Q4 2018, an estimated $1K.
  • Cowen Inc first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Cowen Inc's Pfizer position peaked at $4.24M in Q2 2013.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.